DK1729777T3 - Farmaceutisk sammensætning omfattende et mirtazapinsalat - Google Patents

Farmaceutisk sammensætning omfattende et mirtazapinsalat

Info

Publication number
DK1729777T3
DK1729777T3 DK05740221T DK05740221T DK1729777T3 DK 1729777 T3 DK1729777 T3 DK 1729777T3 DK 05740221 T DK05740221 T DK 05740221T DK 05740221 T DK05740221 T DK 05740221T DK 1729777 T3 DK1729777 T3 DK 1729777T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
salad
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK05740221T
Other languages
Danish (da)
English (en)
Inventor
Sytske Hyke Moolenaar
Gerardus Johannes Kemperman
Der Voort Maarschalk Kees Van
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1729777T3 publication Critical patent/DK1729777T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK05740221T 2004-04-21 2005-04-19 Farmaceutisk sammensætning omfattende et mirtazapinsalat DK1729777T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21
PCT/EP2005/051714 WO2005102352A1 (en) 2004-04-21 2005-04-19 Pharmaceutical composition comprising a salt of mirtazapine

Publications (1)

Publication Number Publication Date
DK1729777T3 true DK1729777T3 (da) 2009-06-08

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05740221T DK1729777T3 (da) 2004-04-21 2005-04-19 Farmaceutisk sammensætning omfattende et mirtazapinsalat

Country Status (31)

Country Link
US (1) US20070111993A1 (enExample)
EP (1) EP1729777B1 (enExample)
JP (2) JP5260959B2 (enExample)
CN (2) CN1942191B (enExample)
AR (1) AR049028A1 (enExample)
AT (1) ATE424210T1 (enExample)
AU (1) AU2005235383B2 (enExample)
BR (1) BRPI0509953A (enExample)
CA (1) CA2561281C (enExample)
CY (1) CY1109018T1 (enExample)
DE (1) DE602005013066D1 (enExample)
DK (1) DK1729777T3 (enExample)
EC (1) ECSP066938A (enExample)
ES (1) ES2321961T3 (enExample)
HR (1) HRP20090190T1 (enExample)
IL (1) IL178201A (enExample)
LV (1) LV13556B (enExample)
MX (1) MXPA06011830A (enExample)
MY (1) MY144899A (enExample)
NO (1) NO20065077L (enExample)
NZ (1) NZ550052A (enExample)
PE (1) PE20060400A1 (enExample)
PL (1) PL1729777T3 (enExample)
PT (1) PT1729777E (enExample)
RS (1) RS50764B (enExample)
RU (1) RU2375362C2 (enExample)
SI (1) SI1729777T1 (enExample)
TW (1) TW200538100A (enExample)
UA (1) UA89773C2 (enExample)
WO (1) WO2005102352A1 (enExample)
ZA (1) ZA200608305B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
ES2212550T3 (es) * 1998-04-02 2004-07-16 Akzo Nobel N.V. Solucion oral liquida que comprende el antidepresor mirtazapina.
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
HK1047547B (en) * 2000-04-05 2003-10-10 Akzo Nobel N.V. Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug

Also Published As

Publication number Publication date
JP2007533705A (ja) 2007-11-22
BRPI0509953A (pt) 2007-09-25
US20070111993A1 (en) 2007-05-17
AU2005235383A1 (en) 2005-11-03
ECSP066938A (es) 2006-12-20
PE20060400A1 (es) 2006-05-27
IL178201A0 (en) 2006-12-31
ATE424210T1 (de) 2009-03-15
NZ550052A (en) 2010-02-26
PT1729777E (pt) 2009-04-27
AU2005235383B2 (en) 2010-05-27
SI1729777T1 (sl) 2009-08-31
RU2006140988A (ru) 2008-05-27
EP1729777A1 (en) 2006-12-13
RS50764B (sr) 2010-08-31
CN101824035A (zh) 2010-09-08
CN1942191A (zh) 2007-04-04
EP1729777B1 (en) 2009-03-04
CN1942191B (zh) 2011-02-02
MXPA06011830A (es) 2007-03-23
RU2375362C2 (ru) 2009-12-10
JP2013136626A (ja) 2013-07-11
DE602005013066D1 (de) 2009-04-16
WO2005102352A1 (en) 2005-11-03
UA89773C2 (ru) 2010-03-10
CA2561281C (en) 2013-04-02
MY144899A (en) 2011-11-30
ZA200608305B (en) 2008-08-27
IL178201A (en) 2010-06-30
AR049028A1 (es) 2006-06-21
JP5260959B2 (ja) 2013-08-14
LV13556B (en) 2007-07-20
NO20065077L (no) 2006-11-14
CY1109018T1 (el) 2014-07-02
PL1729777T3 (pl) 2009-07-31
CA2561281A1 (en) 2005-11-03
TW200538100A (en) 2005-12-01
ES2321961T3 (es) 2009-06-15
HRP20090190T1 (en) 2009-05-31

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
NO20075628L (no) Farmasøytiske formuleringer
DE602005026188D1 (de) Medikamentenspender
DK2783682T3 (da) Farmaceutisk sammensætning omfattende pimobendan
MA28801B1 (fr) Composition antihistaminique
DE602005020716D1 (de) Fluoroelastomere
DK1957073T3 (da) Lægemiddel
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
EP1798372A4 (en) "MOVING" TYPE DETENDER
EP1949834A4 (en) MODULAR MAT
DK2918286T3 (da) En farmaceutisk formulering
ITMI20042232A1 (it) Composizione farmaceutica contenente clozapina
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
DE602005008045D1 (de) Werbehilfe
NO20045094D0 (no) Emballasje
NO20042027D0 (no) Oral composition
DK1753431T3 (da) Farmaceutisk sammensætning omfattende ZD6474
FI20041361A0 (fi) Pakkausmateriaalit
ES1059039Y (es) Expositor modular
FR2871918B1 (fr) Enseigne modulaire
ES1062686Y (es) Expositor modular
ITMI20040621A1 (it) Composizioni farmaceutiche orali
FI20040558A0 (fi) Farmaseuttinen valmiste